Présenté en anglaisPresented in English🎓 15 h

Multi-specialty update: Artificial intelligence, Dermatology, Endocrinology, Gastroenterology and NephrologyMulti-specialty update: Artificial intelligence, Dermatology, Endocrinology, Gastroenterology and Nephrology

📅 May 12-16, 2026May 12-16, 2026 📍 Artimino et Rapallo, ItalieArtimino and Rapallo, Italy

Informations pratiquesPractical information

RésidentsResidents
150 $
Médecins & pro.Physicians & professionals
495 $
Formation accréditéeAccredited CME
15 h
Public cibleTarget audience
Médecins de famille et spécialistes anglophonesEnglish-speaking family physicians and specialists

Accréditation

This Group Learning program has been certified by the College of Family Physicians of Canada and National and is eligible for up to 15.00 Mainpro+ credits.

No of session : 302858-001
Accrediting organization : Collège des médecins de famille du Canada
Name of the program : Multi-specialty update : artificial intelligence, dermatology, endocrinology, gastroenterology and nephrology
City : Artimino and Rapallo
Start date : 12/05/2026
End date : 16/05/2026

The multi-specialty update : artificial intelligence, dermatology, endocrinology, gastroenterology and nephrology, Artimino and Rapallo, Italy 12/05/2026- 16/05/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 15.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at this link

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Programme scientifique jour par jour

Tuesday, May 12
8:15 am
Word of welcome
8:30 amIncluding a 15-minute period question
Skin cancer detection with the naked eye
Vincent Richer, MD
Dermatologist, Pacific Derm
By the end of this presentation, participants will be able to :
  • Describe the typical morphology of the three most common types of skin cancer: basal cell carcinoma, squamous cell carcinoma and melanoma
  • Apply magnification, pattern recognition, systematic skin examination, palpation and other bedside techniques to optimize skin cancer screening
  • Select an appropriate biopsy technique based on your clinical suspicion
9:30 amIncluding a 15-minute period question
Isotretinoin bootcamp
Vincent Richer, MD
Dermatologist, Pacific Derm
By the end of this presentation, participants will be able to :
  • Identify patients who are candidates to benefit from isotretinoin treatment
  • Prescribe appropriate laboratory monitoring during isotretinoin treatment
  • Discuss informed consent regarding isotretinoin, including related to controversies such as the effect on mood disorders, inflammatory bowel disease and the timing of elective procedures
10:30 am
Break
10:45 amIncluding a 15-minute period question
Aesthetic medical procedures – recognizing complications
Vincent Richer, MD
Dermatologist, Pacific Derm
By the end of this presentation, participants will be able to :
  • Describe the different cosmetic treatment categories that address skin quality, dynamic lines and loss of volume/elasticity
  • Recognize complications from cosmetic treatments of the skin
  • Identify the clinical scenarios where watchful waiting is advised vs. situations where intervention may benefit the patient
11:45 am
Group Lunch (included for everyone)
1:15 pmIncluding a 15-minute period question
IBS: The Basics
Edmond-Jean Bernard, MD
Gastroenterologist, CHUM
By the end of this presentation, participants will be able to :
  • Understand the underlying pathophysiology
  • Examine the do’s and don’ts of the diagnostic work up
  • Explore the various therapeutic approaches
2:15 pmIncluding a 15-minute period question
IBD management in general practice: a 101 approach
Edmond-Jean Bernard, MD
Gastroenterologist, CHUM
By the end of this presentation, participants will be able to :
  • Examine the clinical approaches to an IBD diagnosis
  • Understand the fundamentals of UC and Crohn’s Disease therapies
  • Understand the place of a family physician in an iBD patient’s journey
3:15 pm
Break
3:30 pmIncluding a 15-minute period question
Clinical approach to common Gastro-intestinal syndromes: Dysphagia, Diarrhea, Constipation, Bloating, Nausea and Vomiting
Edmond-Jean Bernard, MD
Gastroenterologist, CHUM
By the end of this presentation, participants will be able to :
  • Understand the underlying pathophysiology
  • Examine the various diagnostic approaches
Wednesday, May 13
8:45 amIncluding a 15-minute period question
Indications for Dialysis
Louise Vitou, MD
Nephrologist, Kitchener
By the end of this presentation, participants will be able to :
  • Compare review of Hemodialysis and Peritoneal Dialysis
  • Manage complications of Renal Failure
  • Discuss biochemical indications for Dialysis
  • Present the volume indications for Dialysis
  • Review the symptoms of uremia
9:45 am
Break
10:00 amIncluding a 30-minute period question
Peritoneal Dialysis for Cardio Renal Syndrome
Louise Vitou, MD
Nephrologist, Kitchener
By the end of this presentation, participants will be able to :
  • Review evolving definition of Cardio Renal Syndrome
  • Integrate hemodynamic, neurohormonal, inflammatory and cellular pathways
  • Discuss clinical implications, bio markers, and therapeutic strategies
Friday, May 15
8:30 amIncluding a 15-minute period question
GLP1 Agonists ; when to start for diabetes and obesity tricks and tips
Tina Kader, MDCM, FRCP, CDE
Endocrinologist, CVPH
By the end of this presentation, participants will be able to :
  • Identify when to use GLP1 agonists for diabetes and obesity
  • Determine the difference between available GLP1 agonists and which one to choose
  • Propose tricks on how to start these agents and how best to manage when side effects occur
9:30 amIncluding a 15-minute period question
Diabetes type 2 uncontrolled
Tina Kader, MDCM, FRCP, CDE
Endocrinologist, CVPH
By the end of this presentation, participants will be able to :
  • Define poorly controlled diabetes ; based on individual cases
  • Recommend what next after metformin ; SLGT2 inhibitor and GLP1 agonist
  • Determine the role for insulin in management if type 2 diabetes
10:30 am
Break
10:45 amIncluding a 15-minute period question
History of insulin
Tina Kader, MDCM, FRCP, CDE
Endocrinologist, CVPH
By the end of this presentation, participants will be able to :
  • Resume the start of insulin therapy over 100 years ago and how it has evolved
  • Recall second generation basal insulins and when to use in practice
  • Discover the role of weekly basal insulin and how to use in your practice
Saturday, May 16
8:00 amIncluding a 15-minute period question
Understanding AI in Medicine — From Data to Decisions
James Tsui, BEng, MSc, MDCM, PhD, FRCPC
Assistant professor, McGill
By the end of this presentation, participants will be able to :
  • Describe how machine learning “learns”
  • Illustrate in simple terms how computers recognize patterns
  • Explain how different types of data are represented (numbers, images, text, signals)
9:00 amIncluding a 15-minute period question
Imaging Data — How AI Reads What We See (and Miss)
James Tsui, BEng, MSc, MDCM, PhD, FRCPC
Assistant professor, McGill
By the end of this presentation, participants will be able to :
  • Explain how AI analyzes medical images
  • Show how models can detect features invisible to the human eye
  • Present real examples from radiology, dermatology, and oncology
10:00 am
Break
10:15 amIncluding a 15-minute period question
Language Models — Making Sense of Medical Text
James Tsui, BEng, MSc, MDCM, PhD, FRCPC
Assistant professor, McGill
By the end of this presentation, participants will be able to :
  • Define what language models are and how they are trained to read and write
  • Explain the evolution from early models to today’s large language models (LLMs)
  • Demonstrate applications in summarizing notes, assisting triage, and supporting decision-making